|
EP0187703B1
(en)
*
|
1985-01-11 |
1992-08-05 |
Teijin Limited |
Sustained release preparation
|
|
US4863456A
(en)
*
|
1986-04-30 |
1989-09-05 |
Alza Corporation |
Dosage form with improved delivery capability
|
|
US4970075A
(en)
|
1986-07-18 |
1990-11-13 |
Euroceltique, S.A. |
Controlled release bases for pharmaceuticals
|
|
US4861598A
(en)
*
|
1986-07-18 |
1989-08-29 |
Euroceltique, S.A. |
Controlled release bases for pharmaceuticals
|
|
GB8626098D0
(en)
*
|
1986-10-31 |
1986-12-03 |
Euro Celtique Sa |
Controlled release hydromorphone composition
|
|
US4873092A
(en)
*
|
1987-05-21 |
1989-10-10 |
Murata Kikai Kabushiki Kaisha |
Slow-releasing preparation
|
|
US5234957A
(en)
|
1991-02-27 |
1993-08-10 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for topical administration of pharmaceutically active agents
|
|
US5744166A
(en)
*
|
1989-02-25 |
1998-04-28 |
Danbiosyst Uk Limited |
Drug delivery compositions
|
|
US5133974A
(en)
*
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
|
US5178878A
(en)
*
|
1989-10-02 |
1993-01-12 |
Cima Labs, Inc. |
Effervescent dosage form with microparticles
|
|
US5223264A
(en)
|
1989-10-02 |
1993-06-29 |
Cima Labs, Inc. |
Pediatric effervescent dosage form
|
|
US5169645A
(en)
|
1989-10-31 |
1992-12-08 |
Duquesne University Of The Holy Ghost |
Directly compressible granules having improved flow properties
|
|
US5403593A
(en)
*
|
1991-03-04 |
1995-04-04 |
Sandoz Ltd. |
Melt granulated compositions for preparing sustained release dosage forms
|
|
TW209174B
(enExample)
*
|
1991-04-19 |
1993-07-11 |
Takeda Pharm Industry Co Ltd |
|
|
US5288493A
(en)
*
|
1991-05-17 |
1994-02-22 |
National Starch And Chemical Investment Holding Corporation |
Skin care compositions with improved rub-off resistance
|
|
DE69229881T2
(de)
*
|
1991-10-04 |
1999-12-09 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Tablette mit verzögerter freisetzung
|
|
US5656295A
(en)
*
|
1991-11-27 |
1997-08-12 |
Euro-Celtique, S.A. |
Controlled release oxycodone compositions
|
|
US5266331A
(en)
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
|
US5248669A
(en)
*
|
1991-12-17 |
1993-09-28 |
Samir Amer |
Inhibition of anoxia or hypoxia-induced, endothelium-mediated vasospasm with avermectins
|
|
US5472712A
(en)
|
1991-12-24 |
1995-12-05 |
Euroceltique, S.A. |
Controlled-release formulations coated with aqueous dispersions of ethylcellulose
|
|
US5478577A
(en)
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
|
US5580578A
(en)
*
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
US5273760A
(en)
|
1991-12-24 |
1993-12-28 |
Euroceltigue, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
|
US5286493A
(en)
|
1992-01-27 |
1994-02-15 |
Euroceltique, S.A. |
Stabilized controlled release formulations having acrylic polymer coating
|
|
US5958459A
(en)
*
|
1991-12-24 |
1999-09-28 |
Purdue Pharma L.P. |
Opioid formulations having extended controlled released
|
|
US5968551A
(en)
*
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
|
US5681585A
(en)
*
|
1991-12-24 |
1997-10-28 |
Euro-Celtique, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
|
US5321012A
(en)
*
|
1993-01-28 |
1994-06-14 |
Virginia Commonwealth University Medical College |
Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
|
|
IT1264020B
(it)
|
1993-01-28 |
1996-09-09 |
Recordati Chem Pharm |
Procedimento per la preparazione di microgranuli idonei alla sospensione in liquidi
|
|
US5352683A
(en)
*
|
1993-03-05 |
1994-10-04 |
Virginia Commonwealth University Medical College Of Virginia |
Method for the treatment of chronic pain
|
|
US5503846A
(en)
*
|
1993-03-17 |
1996-04-02 |
Cima Labs, Inc. |
Base coated acid particles and effervescent formulation incorporating same
|
|
SE9301057L
(sv)
*
|
1993-03-30 |
1994-10-01 |
Pharmacia Ab |
Beredning med kontrollerad frisättning
|
|
IL110014A
(en)
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
|
US5891471A
(en)
*
|
1993-11-23 |
1999-04-06 |
Euro-Celtique, S.A. |
Pharmaceutical multiparticulates
|
|
US5500227A
(en)
*
|
1993-11-23 |
1996-03-19 |
Euro-Celtique, S.A. |
Immediate release tablet cores of insoluble drugs having sustained-release coating
|
|
KR100354702B1
(ko)
|
1993-11-23 |
2002-12-28 |
유로-셀티크 소시에떼 아노뉨 |
약학조성물의제조방법및서방형조성물
|
|
US6210714B1
(en)
*
|
1993-11-23 |
2001-04-03 |
Euro-Celtique S.A. |
Immediate release tablet cores of acetaminophen having sustained-release coating
|
|
GB9401894D0
(en)
|
1994-02-01 |
1994-03-30 |
Rhone Poulenc Rorer Ltd |
New compositions of matter
|
|
US5458879A
(en)
*
|
1994-03-03 |
1995-10-17 |
The Procter & Gamble Company |
Oral vehicle compositions
|
|
DE4413350A1
(de)
*
|
1994-04-18 |
1995-10-19 |
Basf Ag |
Retard-Matrixpellets und Verfahren zu ihrer Herstellung
|
|
US5965161A
(en)
*
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
|
US20020006438A1
(en)
|
1998-09-25 |
2002-01-17 |
Benjamin Oshlack |
Sustained release hydromorphone formulations exhibiting bimodal characteristics
|
|
US5585115A
(en)
*
|
1995-01-09 |
1996-12-17 |
Edward H. Mendell Co., Inc. |
Pharmaceutical excipient having improved compressability
|
|
IL116674A
(en)
*
|
1995-01-09 |
2003-05-29 |
Mendell Co Inc Edward |
Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
|
|
US5674895A
(en)
*
|
1995-05-22 |
1997-10-07 |
Alza Corporation |
Dosage form comprising oxybutynin
|
|
US5607697A
(en)
|
1995-06-07 |
1997-03-04 |
Cima Labs, Incorporated |
Taste masking microparticles for oral dosage forms
|
|
JP4020983B2
(ja)
*
|
1995-07-07 |
2007-12-12 |
帝國製薬株式会社 |
持続性製剤およびその製法
|
|
GB9519363D0
(en)
|
1995-09-22 |
1995-11-22 |
Euro Celtique Sa |
Pharmaceutical formulation
|
|
US5811126A
(en)
*
|
1995-10-02 |
1998-09-22 |
Euro-Celtique, S.A. |
Controlled release matrix for pharmaceuticals
|
|
AU2068797A
(en)
*
|
1996-01-29 |
1997-08-20 |
Edward Mendell Co. Inc. |
Sustained release excipient
|
|
US6245351B1
(en)
*
|
1996-03-07 |
2001-06-12 |
Takeda Chemical Industries, Ltd. |
Controlled-release composition
|
|
KR100341829B1
(ko)
|
1996-03-08 |
2002-08-22 |
니코메드 덴마크 에이/에스 |
방출특성이변형된다-유니트투여량조성물
|
|
US20020110595A1
(en)
*
|
1996-06-28 |
2002-08-15 |
Basf Corporation |
Slow release pharmaceutical compositions
|
|
JP3511042B2
(ja)
|
1996-06-28 |
2004-03-29 |
ソニー株式会社 |
ヒートシュリンクバンド用鋼板
|
|
US6238704B1
(en)
*
|
1996-09-13 |
2001-05-29 |
Shionogi & Co., Ltd. |
Sustained-release preparation utilizing thermal change and process for the production thereof
|
|
US6375987B1
(en)
*
|
1996-10-01 |
2002-04-23 |
Gattefossé, S.A. |
Process for the manufacture of pharmaceutical composition with modified release of active principle comprising the matrix
|
|
FR2753904B1
(fr)
*
|
1996-10-01 |
1998-10-30 |
Gattefosse Ets Sa |
Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
|
|
BE1011045A3
(fr)
*
|
1997-03-14 |
1999-04-06 |
Ucb Sa |
Compositions pharmaceutiques pour la liberation controlee de substances actives.
|
|
US5904927A
(en)
*
|
1997-03-14 |
1999-05-18 |
Northeastern University |
Drug delivery using pH-sensitive semi-interpenetrating network hydrogels
|
|
DE69838393T2
(de)
|
1997-04-01 |
2008-01-17 |
Cima Labs Inc., Eden Prairie |
Blisterverpackung für tabletten
|
|
US6024981A
(en)
*
|
1997-04-16 |
2000-02-15 |
Cima Labs Inc. |
Rapidly dissolving robust dosage form
|
|
FR2766708B1
(fr)
*
|
1997-07-30 |
2000-05-05 |
Galenix Dev |
Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethylcellulose et/ou de l'ethylcellullose a titre d'agents desintegrants, et procede d'obtention
|
|
US5851555A
(en)
|
1997-08-15 |
1998-12-22 |
Fuisz Technologies Ltd. |
Controlled release dosage forms containing water soluble drugs
|
|
US6607751B1
(en)
*
|
1997-10-10 |
2003-08-19 |
Intellipharamaceutics Corp. |
Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
|
|
US20040028735A1
(en)
*
|
1997-11-14 |
2004-02-12 |
Unchalee Kositprapa |
Pharmaceutical formulation
|
|
US6251430B1
(en)
*
|
1998-02-04 |
2001-06-26 |
Guohua Zhang |
Water insoluble polymer based sustained release formulation
|
|
US6245357B1
(en)
*
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
|
US6200604B1
(en)
*
|
1998-03-27 |
2001-03-13 |
Cima Labs Inc. |
Sublingual buccal effervescent
|
|
US6372254B1
(en)
*
|
1998-04-02 |
2002-04-16 |
Impax Pharmaceuticals Inc. |
Press coated, pulsatile drug delivery system suitable for oral administration
|
|
US6368625B1
(en)
|
1998-08-12 |
2002-04-09 |
Cima Labs Inc. |
Orally disintegrable tablet forming a viscous slurry
|
|
EP2127642A3
(en)
|
1998-08-13 |
2010-02-24 |
Cima Labs, Inc. |
Microemulsions as solid dosage forms for oral administration
|
|
US6126967A
(en)
|
1998-09-03 |
2000-10-03 |
Ascent Pediatrics |
Extended release acetaminophen particles
|
|
SE9803239D0
(sv)
*
|
1998-09-24 |
1998-09-24 |
Diabact Ab |
Composition for the treatment of acute pain
|
|
US6033686A
(en)
*
|
1998-10-30 |
2000-03-07 |
Pharma Pass Llc |
Controlled release tablet of bupropion hydrochloride
|
|
HU230454B1
(hu)
|
1998-11-02 |
2016-07-28 |
Alkermes Pharma Ireland Limited |
Metilfenidátot tartalmazó módosított felszabadulású sokszemcsés készítmény
|
|
US7767708B2
(en)
*
|
1998-11-04 |
2010-08-03 |
Schering-Plough Animal Health Corp. |
Growth stimulant compositions
|
|
US6740341B1
(en)
|
1998-11-25 |
2004-05-25 |
Cima Labs Inc. |
Taste masking rapid release coating system
|
|
PE20001396A1
(es)
*
|
1999-01-18 |
2000-12-23 |
Gruenenthal Chemie |
Formulaciones medicamentosas retardadas que contienen una combinacion de un opioide o una sal fisiologicamente tolerables del mismo, un o-agonista
|
|
DE19901687B4
(de)
*
|
1999-01-18 |
2006-06-01 |
Grünenthal GmbH |
Opioide Analgetika mit kontrollierter Wirkstofffreisetzung
|
|
KR100845769B1
(ko)
*
|
1999-02-03 |
2008-07-11 |
파우더젝트 리서치 리미티드 |
하이드로겔 입자 제제
|
|
US7374779B2
(en)
*
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
|
US6680071B1
(en)
*
|
1999-03-03 |
2004-01-20 |
R. P. Scherer Technologies, Inc. |
Opioid agonist in a fast dispersing dosage form
|
|
ES2247749T3
(es)
*
|
1999-07-02 |
2006-03-01 |
Cognis Ip Management Gmbh |
Microcapsulas iii.
|
|
EP1064912B1
(de)
*
|
1999-07-02 |
2004-01-28 |
Cognis Iberia, S.L. |
Mikrokapseln - I
|
|
DE19932603A1
(de)
*
|
1999-07-13 |
2001-01-25 |
Gruenenthal Gmbh |
Wirkstoffhaltiger Mehrschichtfilm aus in situ vernetzten hydrophilen Polymeren
|
|
US6500459B1
(en)
|
1999-07-21 |
2002-12-31 |
Harinderpal Chhabra |
Controlled onset and sustained release dosage forms and the preparation thereof
|
|
US20030118641A1
(en)
*
|
2000-07-27 |
2003-06-26 |
Roxane Laboratories, Inc. |
Abuse-resistant sustained-release opioid formulation
|
|
SE9903236D0
(sv)
*
|
1999-09-10 |
1999-09-10 |
Astra Ab |
Method to obtain microparticles
|
|
CA2854796A1
(en)
|
1999-11-09 |
2001-05-17 |
Purdue Pharma |
Hydromorphinone and hydrocodeinone compositions and methods for their synthesis
|
|
DK1175220T3
(da)
*
|
1999-12-08 |
2005-08-29 |
Pharmacia Corp |
Nanopartikulære eplerenonkompositioner
|
|
SI1299104T1
(sl)
|
2000-02-08 |
2009-10-31 |
Euro Celtique Sa |
Oralne formulacije opioidnih agonistov, varne pred zlorabo
|
|
JP3419729B2
(ja)
*
|
2000-03-16 |
2003-06-23 |
株式会社ファンケル |
錠剤およびその製造方法
|
|
US6419954B1
(en)
*
|
2000-05-19 |
2002-07-16 |
Yamanouchi Pharmaceutical Co., Ltd. |
Tablets and methods for modified release of hydrophilic and other active agents
|
|
CN101317825A
(zh)
|
2000-10-30 |
2008-12-10 |
欧罗赛铁克股份有限公司 |
控释氢可酮制剂
|
|
CA2437754C
(en)
*
|
2001-02-15 |
2010-05-18 |
Tanabe Seiyaku Co., Ltd. |
Tablets quickly disintegrated in oral cavity
|
|
US6692771B2
(en)
|
2001-02-23 |
2004-02-17 |
Cima Labs Inc. |
Emulsions as solid dosage forms for oral administration
|
|
UA81224C2
(uk)
*
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
|
US20030004177A1
(en)
|
2001-05-11 |
2003-01-02 |
Endo Pharmaceuticals, Inc. |
Abuse-resistant opioid dosage form
|
|
US7052706B2
(en)
*
|
2001-06-08 |
2006-05-30 |
Nostrum Pharmaceuticals, Inc. |
Control release formulation containing a hydrophobic material as the sustained release agent
|
|
EP1392250A2
(en)
*
|
2001-06-08 |
2004-03-03 |
Endo Pharmaceuticals Inc. |
Controlled release dosage forms using acrylic polymer, and process for making the same
|
|
KR20040060917A
(ko)
*
|
2001-08-06 |
2004-07-06 |
유로-셀티크 소시에떼 아노뉨 |
오피오이드 남용을 방지하기 위한 조성물 및 방법
|
|
EP1414413A1
(en)
*
|
2001-08-06 |
2004-05-06 |
Euro-Celtique S.A. |
Compositions and methods to prevent abuse of opioids
|
|
JP4848101B2
(ja)
|
2001-08-17 |
2011-12-28 |
株式会社フジモト・コーポレーション |
徐放性マイクロペレット
|
|
EP1429744A1
(en)
|
2001-09-21 |
2004-06-23 |
Egalet A/S |
Morphine polymer release system
|
|
US6863901B2
(en)
*
|
2001-11-30 |
2005-03-08 |
Collegium Pharmaceutical, Inc. |
Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
|
|
US20040052843A1
(en)
|
2001-12-24 |
2004-03-18 |
Lerner E. Itzhak |
Controlled release dosage forms
|
|
KR100540035B1
(ko)
*
|
2002-02-01 |
2005-12-29 |
주식회사 태평양 |
다단계 경구 약물 방출 제어 시스템
|
|
ES2320748T5
(es)
|
2002-04-05 |
2017-02-20 |
Euro-Celtique S.A. |
Matriz para la liberación sostenida, invariable e independiente de compuestos activos
|
|
US20050106249A1
(en)
*
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
|
US8557291B2
(en)
|
2002-07-05 |
2013-10-15 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent pharmaceutical compositions of opioids and other drugs
|
|
US7399488B2
(en)
|
2002-07-05 |
2008-07-15 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent pharmaceutical compositions of opiods and other drugs
|
|
US20040208936A1
(en)
|
2002-07-22 |
2004-10-21 |
Roland Chorin |
Novel compositions
|
|
US7985422B2
(en)
*
|
2002-08-05 |
2011-07-26 |
Torrent Pharmaceuticals Limited |
Dosage form
|
|
EP1894562B1
(en)
|
2002-08-15 |
2010-12-15 |
Euro-Celtique S.A. |
Pharmaceutical compositions comprising an opioid antagonist
|
|
US20040052844A1
(en)
*
|
2002-09-16 |
2004-03-18 |
Fang-Hsiung Hsiao |
Time-controlled, sustained release, pharmaceutical composition containing water-soluble resins
|
|
AU2003272601B2
(en)
*
|
2002-09-20 |
2009-05-07 |
Alpharma Pharmaceuticals, Llc |
Sustained-release opioid formulations and methods of use
|
|
EP2422773A3
(en)
*
|
2002-09-20 |
2012-04-18 |
Alpharma, Inc. |
Sequestering subunit and related compositions and methods
|
|
CA2499994C
(en)
*
|
2002-09-23 |
2012-07-10 |
Verion, Inc. |
Abuse-resistant pharmaceutical compositions
|
|
US7192966B2
(en)
*
|
2002-11-15 |
2007-03-20 |
Branded Products For The Future |
Pharmaceutical composition
|
|
ES2645930T3
(es)
*
|
2003-01-03 |
2017-12-11 |
Supernus Pharmaceuticals, Inc. |
Utilización de una mezcla de dos o más materiales entéricos para regular la liberación de fármacos a través de una membrana o matriz para terapias sistémicas
|
|
CN100500130C
(zh)
*
|
2003-01-23 |
2009-06-17 |
株式会社太平洋 |
缓释制剂及其制备方法
|
|
US20040157784A1
(en)
*
|
2003-02-10 |
2004-08-12 |
Jame Fine Chemicals, Inc. |
Opiod tannate compositions
|
|
EP1782834A3
(en)
|
2003-03-13 |
2007-08-01 |
Controlled Chemicals, Inc. |
Oxycodone conjugates with lower abuse potential and extended duration of action
|
|
DE602004024963D1
(de)
*
|
2003-03-13 |
2010-02-25 |
Controlled Chemicals Inc |
Oxycodon- konjugate mit niedrigerem missbrauch- potential und ausgedehnter tätigkeitsdauer
|
|
BRPI0408323A
(pt)
*
|
2003-03-14 |
2006-03-07 |
Nirmal Mulye |
processo para a preparação de compimidos de liberação prolongada
|
|
SE0300831D0
(sv)
|
2003-03-26 |
2003-03-26 |
Pharmacia Ab |
New formulations and use therof
|
|
DE602004031096D1
(de)
*
|
2003-03-26 |
2011-03-03 |
Egalet As |
Morphin-system mit kontrollierter freisetzung
|
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
|
AU2004232370B2
(en)
|
2003-04-21 |
2009-12-10 |
Euro-Celtique S.A. |
Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same
|
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
|
US7790201B2
(en)
*
|
2003-09-03 |
2010-09-07 |
Mallinckrodt Inc. |
Granular sustained release preparation and production thereof
|
|
US20050053656A1
(en)
*
|
2003-09-05 |
2005-03-10 |
Ping Jeffrey H. |
Compositions and methods for treating pain
|
|
US20090304793A1
(en)
|
2003-09-22 |
2009-12-10 |
Alpharma, Inc. |
Sustained release opioid formulations and methods of use
|
|
US20050158382A1
(en)
|
2003-09-26 |
2005-07-21 |
Evangeline Cruz |
Controlled release formulations of opioid and nonopioid analgesics
|
|
WO2005034859A2
(en)
*
|
2003-10-03 |
2005-04-21 |
Elite Laboratories Inc. |
Extended release formulations of opioids and method of use thereof
|
|
CN102078310B
(zh)
*
|
2003-12-31 |
2013-01-23 |
奇马实验室公司 |
大体线性的泡腾口服芬太尼剂型和施用方法
|
|
US20050165038A1
(en)
*
|
2004-01-22 |
2005-07-28 |
Maxwell Gordon |
Analgetic dosage forms that are resistant to parenteral and inhalation dosing and have reduced side effects
|
|
GB0408308D0
(en)
|
2004-04-14 |
2004-05-19 |
Vectura Ltd |
Pharmaceutical compositions
|
|
US20060024361A1
(en)
*
|
2004-07-28 |
2006-02-02 |
Isa Odidi |
Disintegrant assisted controlled release technology
|
|
FR2878161B1
(fr)
*
|
2004-11-23 |
2008-10-31 |
Flamel Technologies Sa |
Forme medicamenteuse orale, solide et concue pour eviter le mesusage
|
|
US20060177380A1
(en)
|
2004-11-24 |
2006-08-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
US20070231268A1
(en)
|
2004-11-24 |
2007-10-04 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
EP1771160A2
(en)
*
|
2005-01-28 |
2007-04-11 |
Euroceltique S.A. |
Alcohol resistant dosage forms
|
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
FR2881652B1
(fr)
*
|
2005-02-08 |
2007-05-25 |
Flamel Technologies Sa |
Forme pharmaceutique orale microparticulaire anti-mesuage
|
|
US20060263429A1
(en)
|
2005-05-20 |
2006-11-23 |
Hengsheng Feng |
Compressible mixture, compressed pharmaceutical compositions, and method of preparation thereof
|
|
RU2008104638A
(ru)
*
|
2005-07-07 |
2009-08-20 |
Фарнэм Компаниз, Инк. (Us) |
Фармацевтические композиции хорошо растворимых в воде лекарственных средств, обеспечивающих их замедленное высвобождение
|
|
US20090082466A1
(en)
|
2006-01-27 |
2009-03-26 |
Najib Babul |
Abuse Resistant and Extended Release Formulations and Method of Use Thereof
|
|
US20090317355A1
(en)
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
ZA200807571B
(en)
|
2006-03-01 |
2009-08-26 |
Ethypharm Sa |
Crush-resistant tablets intended to prevent accidental misuse and unlawful diversion
|
|
US20070212414A1
(en)
|
2006-03-08 |
2007-09-13 |
Penwest Pharmaceuticals Co. |
Ethanol-resistant sustained release formulations
|
|
US20080069891A1
(en)
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
|
WO2008140460A1
(en)
|
2007-05-16 |
2008-11-20 |
Fmc Corporation |
Solid form
|
|
JP5204847B2
(ja)
|
2007-09-21 |
2013-06-05 |
エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング |
エタノールの影響に対して耐性を有するｐｈ依存性制御放出医薬オピオイド組成物
|
|
ATE455538T1
(de)
|
2007-11-09 |
2010-02-15 |
Acino Pharma Ag |
Retardtabletten mit hydromorphon
|
|
KR101660996B1
(ko)
|
2008-09-16 |
2016-09-28 |
넥타르 테라퓨틱스 |
남용에 대한 낮은 잠재성을 갖는 페길화 오피오이드
|